HC, S., ZY, H., T, W., L, L., XD, Z., E, Z., . . . J, Z. (2025). Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study. Dove Medical Press.
Chicago Style (17th ed.) CitationHC, Sun, et al. Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study. Dove Medical Press, 2025.
MLA (9th ed.) CitationHC, Sun, et al. Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.